Skip to main content

Table 1 Baseline demographic and clinical characteristics of the participants

From: A randomised clinical trial to evaluate the effects of Plantago ovata husk in Parkinson patients: changes in levodopa pharmacokinetics and biochemical parameters

  Group 1 (n = 9) Group 2 (n = 9)
Sex (Men/Women) (5/4) (5/4)
Age (Mean ± SD) (years) 68.7 ± 3.1 70.3 ± 4.3
Disease duration (Mean ± SD) (years) 1.4 ± 0.6 1.3 ± 0.4
Duration of levodopa treatment (Mean ± SD) (years) 0.7 ± 0.3 0.8 ± 0.5